PALM SPRINGS, CALIFORNIA (GenomeWeb) – The 2016 edition of the Mass Spectrometry: Applications to the Clinical Lab US (MSACL) conference highlighted the continued challenges of aligning the technology with the broader agenda of the diagnostics field.

The mass spec-based diagnostics field is like a water balloon; it is set to be squeezed on one end by impending regulation of laboratory-developed tests, but also to expand as matrix-assisted laser desorption/ionization (MALDI) mass spec platforms gain greater adoption in the clinical market.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.